👀 Watchlist Winners: Copy Legendary Investors' Portfolios in One ClickCOPY FOR FREE

Atomera stock price target cut to $7 from $13 by Craig-Hallum

EditorIsmeta Mujdragic
Published 07/31/2024, 11:09 AM
ATOM
-

On Wednesday, Craig-Hallum adjusted its outlook on Atomera (NASDAQ:ATOM), reducing the price target to $7.00 from the previous $13.00. Despite the decrease, the firm maintained a Buy rating on the stock. The analyst at Craig-Hallum highlighted that Atomera's business model remains highly leveraged and, in light of the stock's decline this year, it represents an attractive entry point for investors willing to accept higher risk.

The second-quarter update from Atomera did not reveal any definitive milestones, but it did indicate that negotiations with JDA2 have begun. Additionally, the company expects to see some revenue from GaN this year and anticipates progress with STM potentially leading to revenue by the end of the year. The analyst noted the potential for significant returns driven by catalysts in the upcoming quarters.

The firm acknowledged that the market's anticipation for rapid gains, especially after the initial surge following the STM announcement, has been tempered by the scarcity of announcements and balance sheet concerns. These concerns have contributed to the stock's decline of over 55% year-to-date. However, the analyst believes that the current low price could offer an upside opportunity for investors.

Craig-Hallum underscored the importance of STM moving to production, which would be a pivotal moment for Atomera. This step could reduce risks for other companies in earlier evaluation stages and mark Atomera's "Zero To One" moment. The analyst reiterated the firm's Buy rating, adjusting the price target to reflect the balance of potential rewards against the risks presented by the current market conditions.

InvestingPro Insights

As investors consider the adjusted outlook on Atomera provided by Craig-Hallum, real-time data from InvestingPro offers additional context to the company's financial health and market performance. Atomera currently holds a market capitalization of $99.21 million, with a notably high revenue growth rate in the last twelve months as of Q1 2023, at 8014.29%. This growth is underscored by an impressive gross profit margin of 89.26%, indicating strong profitability on its products or services.

Despite these positive indicators, Atomera's price has experienced significant volatility, with a 1-year price total return of -64.08%, trading near its 52-week low at 33.73% of the peak. This aligns with the Craig-Hallum analyst's view of Atomera as a higher risk investment opportunity with potential for significant returns. Two InvestingPro Tips that may be particularly relevant for prospective investors are: Atomera holds more cash than debt on its balance sheet, suggesting a degree of financial stability, and analysts anticipate sales growth in the current year, indicating potential for future expansion.

For investors seeking more detailed analysis and additional InvestingPro Tips, there are 17 more tips available to help guide investment decisions. To access these insights, consider subscribing to InvestingPro, and use the coupon code PRONEWS24 to get up to 10% off a yearly Pro and a yearly or biyearly Pro+ subscription.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.